1-9 of 9
Authors: Zachariah Tritz
Journal Article
IMMU-44. CIRCULATING CELL-FREE DNA DIRECTLY INHIBITS T CELL FUNCTION AND CONTRIBUTES TO PERIPHERAL IMMUNOSUPPRESSION IN EXPERIMENTAL GBM Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v152, https://doi.org/10.1093/neuonc/noad179.0576
Published: 10 November 2023
Journal Article
EXTH-77. EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH Α-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v242, https://doi.org/10.1093/neuonc/noad179.0930
Published: 10 November 2023
Journal Article
IMMU-26. HEIGHTENED LEVELS OF CIRCULATING CELL-FREE DNA CONTRIBUTE TO PERIPHERAL IMMUNOSUPPRESSION DURING GBM PROGRESSION Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii136–vii137, https://doi.org/10.1093/neuonc/noac209.523
Published: 14 November 2022
Journal Article
IMMU-36. EVALUATION OF TUMOR DERIVED SERPINA3N IN EXPERIMENTAL GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii139, https://doi.org/10.1093/neuonc/noac209.533
Published: 14 November 2022
Journal Article
EXTH-66. ENHANCEMENT OF ANTI-PD-1 THERAPY WITH EXTENDED HALF-LIFE IL-2 IS INDEPENDENT OF MHC CLASS I RESTRICTED ANTIGEN RECOGNITION FOR TREATMENT OF EXPERIMENTAL GLIOMA Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi178, https://doi.org/10.1093/neuonc/noab196.705
Published: 12 November 2021
Journal Article
IMMU-19. EVALUATING EFFECTS OF REVERSING DISTINCT FACETS OF IMMUNOSUPPRESSION IN EXPERIMENTAL GBM Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi95–vi96, https://doi.org/10.1093/neuonc/noab196.378
Published: 12 November 2021
Journal Article
IMMU-15. HEPARIN INHIBITS THE EXTRACELLULAR VESICLE-MEDIATED INDUCTION OF IMMUNOSUPPRESSIVE MONOCYTES IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii107, https://doi.org/10.1093/neuonc/noaa215.445
Published: 09 November 2020
Journal Article
IMMU-25. SEVERE AND MULTIFACETED SYSTEMIC IMMUNOSUPPRESSION CAUSED BY EXPERIMENTAL CANCERS OF THE CENTRAL NERVOUS SYSTEM REQUIRES RELEASE OF NON-STEROID SOLUBLE MEDIATORS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii110, https://doi.org/10.1093/neuonc/noaa215.455
Published: 09 November 2020
Journal Article
IMMU-22. PHARMACOLOGICALLY TARGETING EXTRACELLULAR VESICLE-IMMUNE CELL INTERACTIONS IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi125–vi126, https://doi.org/10.1093/neuonc/noy148.525
Published: 05 November 2018
